Protein Information

ID 2571
Name cytochrome P450 2A6
Synonyms CPA 6; CPA6; Flavoprotein linked monooxygenase; CYP2A; P450C2A; P450PB; CYP2A3; CYP2A6…

Compound Information

ID 1403
Name naphthalene
CAS naphthalene

Reference

PubMed Abstract RScore(About this table)
19104915 Leong MK, Chen YM, Chen HB, Chen PH: Development of a new predictive model for interactions with human cytochrome P450 2A6 using pharmacophore ensemble/support vector machine (PhE/SVM) approach. Pharm Res. 2009 Apr;26(4):987-1000. Epub 2008 Dec 23.
PURPOSE: The objective of this investigation was to yield a generalized in silico model to quantitatively predict CYP2A6-substrates/inhibitors interactions to facilitate drug discovery. METHODS: The newly invented pharmacophore ensemble/support vector machine (PhE/SVM) scheme was employed to generate the prediction model based on the data compiled from the literature. RESULTS: The predictions by the PhE/SVM model are in good agreement with the experimental observations for those molecules in the training set (n = 24, r (2) = 0.94, q (2) = 0.85, RMSE = 0.30) and the test set (n = 9, r (2) = 0.96, RMSE = 0.29). In addition, this in silico model performed equally well for those molecules in the external validation sets, namely one set of benzene and naphthalene derivatives (n = 45, r (2) = 0.81, RMSE = 0.46) and one set of amine neurotransmitters (n = 4, r (2) = 0.98, RMSE = 0.32). Furthermore, when compared with crystal structures, the calculated results are consistent with the published CYP2A6-substrate co-complex structure and the plasticity nature of CYP2A6 is also revealed. CONCLUSIONS: This PhE/SVM model is an accurate and robust model and can be utilized for predicting interactions with CYP2A6, high-throughput screening and data mining to facilitate drug discovery.
4(0,0,0,4)